Меню
Идёт набор NCT07296887

CARE Tool Study Aim 3

Без фазы С лечением Gynecologic Cancer Prostate Cancer Lung Cancer Colorectal Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Financial education information, CARE Tool, CARE Tool Training.
Кому может быть актуально
Состояния в реестре: Gynecologic Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Implement and Evaluate the CARE Tool in a Randomized Trial

Обзор

This study is a multi-site randomized trial to study the implementation of the CARE Tool and evaluate the CARE Tool. The CARE Tool is a web-based tool that gives people information about cancer care costs, health insurance, and resources to help with costs. Overall, the study aims to help patients with cancer overcome barriers they face navigating insurance and accessing financial resources.

Вмешательства

  • Другое Financial education information
    Standard financial education resources will be provided to patients enrolled in the control arm. Financial education will be accessible via website and provided by the participating site.
  • Другое CARE Tool
    The CARE Tool is a web-based tool provided to patients after enrollment. The CARE Tool provides patients with individualized information about cancer care costs, health insurance, and resources to assist with costs.
  • Другое CARE Tool Training
    Members of the care team who have been identified as implementation champions will undergo training on cost conversations, how to use the CARE Tool, and how to implement the CARE Tool in their clinical workflow.

Первичные конечные точки

  • Patient's comprehensive score for financial toxicity (COST) [Срок оценки: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)]
  • Patient's score of self-efficacy for communicating about care costs measured with the Decision Self-Efficacy Scale [Срок оценки: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)]
  • Patient's health insurance literacy measure (HILM) score [Срок оценки: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)]
Вторичные конечные точки (4)
  • Patient's reported adherence to therapy & delayed care [Срок оценки: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)]
  • Feasibility of Intervention Measure (FIM) - Adapted [Срок оценки: At start of recruitment and at completion recruitment (total estimated time is 2 years)]
  • Acceptability of Intervention Measure (AIM) - Adapted [Срок оценки: At start of recruitment and at completion recruitment (total estimated time is 2 years)]
  • Intervention Appropriateness Measure (IAM) - Adapted [Срок оценки: At start of recruitment and at completion recruitment (total estimated time is 2 years)]

Критерии участия

Inclusion Criteria for Implementation champions:

\- Members of the cancer care team (e.g., physicians, nurses, research coordinators, financial navigators, social workers) that work with patients receiving treatment for gynecologic, lung, prostate, or colorectal cancer; or members of the billing team and employee of Siteman Cancer Center, Barnes Jewish Hospital, Washington University, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital

Exclusion Criteria for Implementation champions:

  • Implementation champions are ineligible if they are non-employees of Siteman Cancer Center, Barnes Jewish Hospital, Washington University, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital
  • Do not treat patients for gynecologic, prostate, lung, or colorectal cancer

Inclusion Criteria for Patients:

  • Age 18 and over
  • Primary or recurrent diagnosis of gynecologic, prostate, lung, or colorectal cancer in the last 12 months
  • Receiving cancer treatment from Siteman Cancer Center, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital
  • Self-reported ability to read and speak English

Exclusion Criteria for Patients:

  • Under the age of 18
  • Not diagnosed with gynecologic, prostate, lung, or colorectal cancer within the previous 12 months from recruitment
  • Not receiving care at Siteman Cancer Center, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital
  • Cannot give consent due to cognitive or emotional barriers

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Организация здравоохранения

Центры проведения

США · 3 центра
  • Alton Memorial Hospital — Alton
  • Delbert Day Cancer Institute at Phelps Health — Rolla
  • Washington University School of Medicine — St Louis

Идентификаторы

NCT: NCT07296887 · 202601127 · U19CA291430

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗